Antimalarial Therapy for Granuloma Annulare: Results of a Retrospective Analysis

    Sungat K. Grewal, Courtney Rubin, Misha Rosenbach
    Studysummary In this study, 55.6% of granuloma annulare patients improved on hydroxychloroquine, with a higher prevalence of thyroid disease observed in the patient cohort.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →